Diclowis - MR is a multifunctional analgesic formulation combining three active ingredients to address complex pain management needs. The tablet contains Diclofenac Potassium (50mg), a nonsteroidal anti-inflammatory drug (NSAID) with potent anti-inflammatory, analgesic, and antipyretic properties; Paracetamol (325mg), a centrally acting analgesic and antipyretic; and Chlorzoxazone (250mg), a muscle relaxant that alleviates musculoskeletal discomfort. The formulation is designed to ensure optimal bioavailability, stability, and compatibility of the active pharmaceutical ingredients (APIs). The tablet is formulated using a direct compression method, incorporating excipients such as microcrystalline cellulose, magnesium stearate, and colloidal silicon dioxide to ensure uniformity, disintegration time, and tablet hardness. The combination of APIs is carefully balanced to enhance therapeutic efficacy while minimizing potential interactions, making it suitable for pharmaceutical manufacturers requiring a robust, scalable formulation.
Manufacturing Capability
Our manufacturing infrastructure is equipped to produce Diclowis - MR with precision and compliance. The facility adheres to current Good Manufacturing Practices (cGMP) and includes state-of-the-art equipment for tablet compression, coating, and packaging. Sterile processing capabilities are available for critical components, ensuring contamination-free production. The manufacturing process is optimized for scalability, allowing seamless transition from small-scale development to large-volume production. Quality systems are integrated throughout the workflow, including real-time monitoring of critical parameters such as tablet weight, hardness, and dissolution profiles. The facility is certified under ISO 9001:2015 and maintains rigorous documentation and traceability systems to meet global pharmaceutical standards.
Available Strengths and Packaging
Diclowis - MR is available in a single strength: Diclofenac Potassium 50mg + Paracetamol 325mg + Chlorzoxazone 250mg. The product is packaged in 10x10 blister packs, ensuring secure storage, tamper-evidence, and ease of distribution. The blister packaging is designed for stability under varied environmental conditions, with a shelf life of up to 24 months when stored as per recommended conditions.
Contract Manufacturing / Third Party Manufacturing
As a trusted pharmaceutical manufacturer, we offer end-to-end contract manufacturing services for Diclowis - MR, including private label and brand-name production. Our capabilities extend to formulation development, API sourcing, and packaging customization to meet specific client requirements. We support third-party manufacturers by providing flexible production schedules, compliance-ready documentation, and adherence to global regulatory standards. Our team collaborates closely with clients to ensure alignment with market demands, enabling rapid time-to-market for pharmaceutical products.
Quality Assurance
Quality assurance for Diclowis - MR is ensured through a comprehensive system of controls, including in-process testing, batch validation, and stability studies. Each batch undergoes rigorous analytical testing using high-performance liquid chromatography (HPLC), dissolution testing, and dissolution profiling to confirm API integrity and uniformity. Finished products are subjected to microbial limit testing, heavy metal analysis, and dissolution efficiency checks to meet international pharmacopoeial standards (USP, EP, BP). Our quality control (QC) laboratory is accredited under ISO/IEC 17025, ensuring consistency, traceability, and compliance with regulatory requirements.
Regulatory Compliance
Diclowis - MR is manufactured in full compliance with Good Manufacturing Practices (GMP), World Health Organization (WHO) guidelines, and international pharmacopoeial standards. The product meets the requirements of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) and adheres to the guidelines of the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other global regulatory bodies. All documentation, including batch records, stability data, and analytical reports, is prepared to meet the specifications of regulatory authorities, ensuring seamless approval processes for global markets.
Global Supply Capability
Our global supply chain is designed to deliver Diclowis - MR to pharmaceutical buyers worldwide. With a robust international distribution network, we ensure timely delivery of bulk orders to key markets, including Asia, Europe, and the Americas. The facility is equipped for large-scale production, enabling consistent supply to meet growing demand. Our logistics partners specialize in pharmaceutical shipping, ensuring compliance with temperature, humidity, and security requirements for sensitive products. We prioritize supply chain reliability through strategic inventory management and contingency planning, guaranteeing uninterrupted delivery to distributors and exporters.
Why Choose Us
Pharmaceutical distributors, exporters, and contract manufacturing partners select us for our expertise in complex formulation development, compliance-driven manufacturing, and global supply chain capabilities. Our commitment to quality, scalability, and regulatory adherence ensures that Diclowis - MR meets the highest standards for international markets. We offer competitive pricing, rapid turnaround times, and dedicated customer support to enhance collaboration and drive business growth.
Bulk Supply Inquiry
For bulk supply inquiries, please contact us at info@delwishealthcare.com. Our team is ready to assist with order placement, customization, and logistics coordination for pharmaceutical buyers seeking reliable, high-quality supply.
FAQs
What is the manufacturing process for Diclowis - MR?
Diclowis - MR is manufactured using a direct compression method, ensuring uniform distribution of active ingredients and excipients. The process includes API blending, tablet compression, and blister packaging to meet quality and regulatory standards.
Does your facility comply with GMP and ISO standards?
Yes, our facility is certified under ISO 9001:2015 and adheres to current Good Manufacturing Practices (cGMP) for pharmaceutical production.
Can you provide documentation for regulatory approvals?
We offer complete documentation, including batch records, stability data, and analytical reports, to support regulatory submissions for global markets.
What is the shelf life of Diclowis - MR?
The product has a shelf life of up to 24 months when stored under recommended conditions (temperature 15–30°C, humidity <60%).
Can you customize packaging for specific markets?
Yes, we offer packaging customization, including blister formats and labeling, to meet regional regulatory and market-specific requirements.
What are the export capabilities for Diclowis - MR?
We have a global distribution network and logistics partnerships to ensure reliable export to key markets, including Asia, Europe, and the Americas.
How do you ensure quality control during production?
Each batch undergoes rigorous testing, including HPLC, dissolution testing, and microbial limit checks, to ensure compliance with pharmacopoeial standards.
Can you produce Diclowis - MR in bulk quantities?
Yes, our facility is designed for large-scale production, enabling consistent bulk supply to meet global demand.
What is the minimum order quantity for bulk supply?
Minimum order quantities are flexible and can be discussed based on production capacity and client requirements.
How can I contact your team for bulk inquiries?
For bulk supply inquiries, please email **info@delwishealthcare.com** for assistance with order placement and logistics coordination.
